U.S., May 10 -- ClinicalTrials.gov registry received information related to the study (NCT06963385) titled 'Radiomics and Molecular Classification in Endometrial Cancer' on Dec. 01, 2020.
Brief Summary: Molecular/genomic profiling is the most accurate method to assess the prognosis of endometrial cancer patients. Interestingly, the adoption of radiomics showed important results, across various oncologic specialties. Radiomic allows extracting mineable high-dimensional data from clinical images, thus providing a number of noteworthy information of the tumor tissues. We aim to correlate radiomic features obtained from ultrasound images with the molecular/genomic profiling to identify new hallmarks for stratification of endometrial cancer pat...